Clinical Resources

Authored and endorsed clinical documents provide three main components vital to advancements in the heart rhythm field: analysis, discussion of current issues, and suggestions for clinical application. 

HRS Clinical Document Methodology

The HRS Clinical Document Development Methodology Manual and Policies transparently declares the standards by which the HRS develops clinical practice documents, which include clinical practice guidelines, expert consensus statements, scientific statements, clinical competency statements, task force policy statements, and proceedings statements.

2012 PACES/HRS Expert Consensus Statement on the Management of the Asymptomatic Young Patient with a Wolff-Parkinson-White (WPW, Ventricular Preexcitation) Electrocardiographic Pattern

Pediatric

May 2012 — The expert consensus statement provides first-of-its-kind clinical practice guidelines on the evaluation and management of asymptomatic young patients with a WPW electrocardiographic pattern. This is also the first collaboration between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS).

2019 HRS Expert Consensus Statement on Evaluation, Risk Stratification, and Management of Arrhythmogenic Cardiomyopathy

Ablation
Atrial Arrhythmias
Clinical Ep
Device Therapy
Heart Failure / CRT
Pediatric
Training
Ventricular Arrhythmias

May 9, 2019 - The expert consensus statement defines the broader condition of arrhythmogenic cardiomyopathy (ACM) that incorporates a spectrum of genetic, systematic, infectious, and inflammatory disorders. The designation includes, but is not limited to, arrhythmogenic right/left ventricular cardiomyopathy, ion channel abnormalities, amyloidosis, and left ventricular noncompaction. The consensus statement provides the clinician with guidance on evaluation and management of ACM and includes clinically relevant information on genetics and disease mechanisms. PICO (Patient, Intervention, Comparison, Outcome) questions were utilized to evaluate contemporary evidence and provide clinical guidance related to exercise in arrhythmogenic right ventricular cardiomyopathy.

The document features a pocket guide, developed in partnership with Guideline Central and available across multiple platforms, including print, electronic media, and the Guideline Central mobile app. Visit www.guidelinecentral.com  to access the pocket guide.

HRS White Paper on Interoperability of Data from Cardiovascular Implantable Electronic Devices

Clinical Ep
Training

May 8, 2019 - This document provides a brief overview of U.S. federal initiatives to promote interoperability of data, the requirements needed to communicate data between information technology systems in a way that permits the sending and receiving systems to understand and process the data, a summary of the work of HRS to date, and finally strategies for clinicians seeking an environment in which they can manage their cardiovascular implantable electronic device (CIED) patient data in a single IT system.

Transparent Sharing of Digital Health Data: A Call to Action

Clinical Ep
Training

May 8, 2019 - Heart rhythm care professionals and patients routinely depend upon digital health data obtained by cardiovascular implantable electronic devices, medical-grade ambulatory cardiac monitors, and most recently consumer personal biometric monitoring devices. Yet the data typically reside either exclusively with the health care team, or, in the case of consumer devices, with the patient. 

Management of Asymptomatic Arrhythmias: a European Heart Rhythm Association (EHRA) Consensus Document

Atrial Arrhythmias
Ventricular Arrhythmias
HRS Endorsed / Affirmed

The Heart Rhythm Society endorsed the document on February 11, 2019.

Asymptomatic arrhythmias are frequently encountered in clinical practice. Although studies specifically dedicated to these asymptomatic arrhythmias are lacking, many arrhythmias still require proper diagnostic and prognostic evaluation and treatment to avoid severe consequences, such as stroke or systemic emboli, heart failure, or sudden cardiac death.